Showing results (1-10 of 934) with videos related to
Sort By:
Pageof 94
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Methotrexate pharmacokinetics and prognosis in osteosarcomaN Graf, K Winkler, M Betlemovic, et al.British Journal of Haematology|August 29, 1998
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trialG Fleischhack, C Hasan, N Graf, et al.Klinische Padiatrie|July 1, 1996
[IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study]G Fleischhack, N Graf, C Hasan, et al.Der Pathologe|January 1, 1996
[Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up]M Werner, N Fuchs, M Salzer-Kuntschik, et al.Klinische Padiatrie|October 21, 2011
Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitalsT Krenn, G Fleischhack, O Moser, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1986
Methotrexate as relapse therapy for rhabdomyosarcomaU BodeAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbsN Fuchs, S S Bielack, D Epler, et al.Pediatric Radiology|January 1, 1988
Change of thymic size during and following cytotoxic therapy in young patientsU Bode, W ScheidtDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 1, 1978
[The acquired digital fibrokeratoma]U Bode, G BurgPageof 94